Updated:
MB Venture Partners
MB Venture Partners is a stage-agnostic venture capital firm. It invests in seed and early-stage financing, with selective later-stage opportunities.
MB Venture Partners
MB Venture Partners is a stage-agnostic venture capital firm. It invests in seed and early-stage financing, with selective later-stage opportunities. The firm primarily invests in biotech and medical devices, having made 88 investments.
General information
Firm type
Venture Capital
Year founded
2001
Location
Region
North America
Country
United States
City
Memphis
Corporate office
17 W Pontotoc Avenue, Suite 101, Memphis, Tennessee 38103
Principals
Gary Stevenson
Co-Founder
Joseph R. “Pitt” Hyde III
Co-Founder
Sector focus
Frequently asked questions
How does MB Venture Partners source proprietary deal flow?
The firm has hosted and sponsored the Musculoskeletal New Ventures Conference for more than two decades. This conference serves as a primary origination channel, bringing together early-stage device companies and potential strategic acquirers. The conference’s longevity gives the firm an embedded network within the orthopedic surgery and musculoskeletal disease sub-sector.
Which sectors does MB Venture Partners explicitly target?
The firm invests primarily in medical device startups focused on musculoskeletal disease. This includes products and technologies relevant to orthopedic surgery, spine treatment, and related surgical interventions. The portfolio’s acquirer list is composed entirely of orthopedic and musculoskeletal strategics.
What investment stages does MB Venture Partners typically target?
The firm states it invests in medical device start-ups at all stages of development, from seed to late-stage venture. This full-stage mandate allows it to back companies from initial product design through expansion and pre-exit growth. No stage-specific fund vehicles have been publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: